Search

Michel M Gensini

from Flemington, NJ
Age ~61
Get Report
Also known as:
Michel Eliane Gensini, Michel A Gensini, Michel E Gensini, Michel M Jensin, Michel I
Phone and address:
26 Amwell Rd, Flemington, NJ 08822
(908) 788-7949
Related to:
Sandra B Gensini, 50Jeffrey J Tober, 74Jeffery ToberEliane G Tober, 55
Connected to:
Asha M Genske, 53Jesse C Genske, 44Trevor W Genske, 49Carla M Genslak, 69Nancy A Genslak, 71Ann M Gensler, 29April L Gensler, 57Betty A Gensler, 96Bonnie R Gensler, 51Christopher Gensler

Michel Gensini Phones & Addresses

  • 26 Amwell Rd, Flemington, NJ 08822 (908) 788-7949
  • Studio City, CA
  • Bridgewater, NJ
  • 1718 Rogers Pl, Burbank, CA 91504
  • 10166 Olivia Ter, Sun Valley, CA 91352 (818) 252-0066 (818) 845-8663
  • Somerset, NJ
  • Oak Ridge, TN

Work

Company: Johnson & johnson Jun 2014 to Aug 2015 Position: Principal scientist

Education

Degree: Bachelors, Bachelor of Science School / High School: University of Liège 1983 to 1988 Specialities: Chemistry

Skills

Drug Delivery • Iso 13485 • Biomaterials • Medical Devices • Design Control • Fda • Biomedical Engineering • R&D • Orthopedic • Formulation • Validation • Biotechnology • Technology Transfer • Capa • Gmp • Glp • Clinical Development • Commercialization • Lifesciences • Pharmaceutical Industry • Life Sciences

Interests

Formula 1 Racing • Dallara Bms 191 • Ski

Industries

Research

Resumes

Resumes

Michel Gensini Photo 1

Scientific Director

View page
Location:
26 Amwell Rd, Flemington, NJ 08822
Industry:
Research
Work:
Johnson & Johnson Jun 2014 - Aug 2015
Principal Scientist
Johnson & Johnson Janssen Pdms Dpd-Lm Jun 2014 - Aug 2015
Scientific Director
Johnson & Johnson Atrm 2007 - 2011
Senior Principal Engineer
Johnson & Johnson 2002 - 2007
Principal Engineer
Isotope Products Laboratories 1994 - 2001
Vice President R and D
Education:
University of Liège 1983 - 1988
Bachelors, Bachelor of Science, Chemistry
Skills:
Drug Delivery
Iso 13485
Biomaterials
Medical Devices
Design Control
Fda
Biomedical Engineering
R&D
Orthopedic
Formulation
Validation
Biotechnology
Technology Transfer
Capa
Gmp
Glp
Clinical Development
Commercialization
Lifesciences
Pharmaceutical Industry
Life Sciences
Interests:
Formula 1 Racing
Dallara Bms 191
Ski

Publications

Us Patents

Absorbable Copolyesters Of Poly(Ethoxyethylene Diglycolate) And Glycolide

View page
US Patent:
7968656, Jun 28, 2011
Filed:
Apr 22, 2008
Appl. No.:
12/107591
Inventors:
Sasa Andjelic - Nanuet NY, US
Jiango Jack Zhou - Bethlehem PA, US
Modesto Erneta - Princeton Junction NJ, US
Michel Gensini - Flemington NJ, US
Assignee:
Ethicon, Inc. - Somerville NJ
International Classification:
C08G 63/00
C08G 59/00
US Classification:
525437, 2642108, 424426, 424497, 442351, 528271, 528272, 528300, 528354
Abstract:
A semi-crystalline, absorbable copolyester composition comprising the reaction product of a polycondensation polyester and at least one lactone, wherein the polycondensation polyester comprises the reaction product of diglycolic acid and/or a derivative thereof and diethylene glycol; and the copolyester comprises about 30 to 60% by weight of the polycondensation polyester based on the total weight of the copolyester. Also medical devices such as absorbable sutures comprising such copolyesters and absorbable microspheres comprising such copolyesters and methods of making of such absorbable microspheres. Additionally, a method of melt blowing an absorbable copolyester composition and a nonwoven construct are disclosed.

Occlusion Of Fallopian Tubes

View page
US Patent:
8042548, Oct 25, 2011
Filed:
Oct 27, 2006
Appl. No.:
12/084185
Inventors:
Robert S. Neuwirth - Englewood NJ, US
Michel Gensini - Flemington NJ, US
Assignee:
Ethicon, Inc. - Somerville NJ
International Classification:
A61F 6/06
A61F 13/20
A61B 17/42
US Classification:
128831, 606119, 604 11, 424430
Abstract:
A method for inducing Fallopian tube blockage as a means for female contraception comprises contacting the inner surface tissue of a Fallopian tube with a silver nitrate bearing substrate and delivering an amount of silver nitrate to the tissue sufficient to induce blockage of the Fallopian tube. At least one silver nitrate bearing bead is introduced through the uterine opening of the Fallopian tube by use of a catheter or other device suitable for manipulating the bead. Alternatively, a plurality of beads can be introduced into the Fallopian tube. In a preferred embodiment, one or more silver nitrate bearing beads are arranged on a string to facilitate later removal of the beads. The method of the present invention delivers an amount of silver nitrate to the tissue sufficient to cause tissue necrosis and blockage of the Fallopian tube.

Absorbable Copolyesters Of Poly(Ethoxyethylene Diglycolate) And Glycolide

View page
US Patent:
20080103285, May 1, 2008
Filed:
Mar 29, 2007
Appl. No.:
11/693118
Inventors:
Sasa Andjelic - Nanuet NY, US
Modesto Erneta - Princeton Junction NJ, US
Michel Gensini - Flemington NJ, US
International Classification:
C08G 63/66
US Classification:
528300
Abstract:
A semi-crystalline, absorbable copolyester composition comprising the reaction product of a polycondensation polyester and at least one lactone, wherein the polycondensation polyester comprises the reaction product of diglycolic acid and/or a derivative thereof and diethylene glycol; and the copolyester comprises about 30 to 60% by weight of the polycondensation polyester based on the total weight of the copolyester. Also medical devices such as absorbable sutures comprising such copolyesters and absorbable microspheres comprising such copolyesters and methods of making of such absorbable microspheres.

Oxidized Regenerated Cellulose Adhesive Tape

View page
US Patent:
20110152924, Jun 23, 2011
Filed:
Dec 22, 2009
Appl. No.:
12/645164
Inventors:
Michel Gensini - Flemington NJ, US
Sanda Gonzalez - Bedminster NJ, US
International Classification:
A61B 17/03
B05D 3/10
US Classification:
606213, 427 231
Abstract:
A novel ORC adhesive tape is disclosed. Specifically, the ORC adhesive tape is useful as an alternative to conventional mechanical and non-mechanical wound closure means. The ORC tape has a tape substrate made from neutralized ORC and it contains an adhesive composition such as a bioabsorbable alpha-cyanoacrylate.

Adhesion Prevention Fabric

View page
US Patent:
20130084324, Apr 4, 2013
Filed:
Sep 30, 2011
Appl. No.:
13/249978
Inventors:
Michel Gensini - Flemington NJ, US
International Classification:
A61K 9/70
A61P 7/04
US Classification:
424445
Abstract:
The present invention is directed to an adhesion prevention fabric having a first absorbable oxidized regenerated cellulose nonwoven fabric and a second absorbable oxidized regenerated cellulose woven or knitted fabric. Further disclosed is an adhesion prevention fabric that is useful for adhesion prevention in the presence of blood.

Multilayer Polymeric Drug Delivery System

View page
US Patent:
20130164347, Jun 27, 2013
Filed:
Dec 21, 2012
Appl. No.:
13/724483
Inventors:
Michel Gensini - Flemington NJ, US
Abla Abu-Zayyad Creasey - Morristown NJ, US
International Classification:
A61K 9/00
US Classification:
424400
Abstract:
The invention relates to a customizable, solvent-free sustained release medical device for wound closure, wound healing, and the sustained release of an active. The device of the invention is composed of at least a polymeric carrier layer and optionally an oxidized regenerated cellulose layer(s). Polymeric barrier layers can be added to modify the release profile (burst, time of release, etc.) of the selected bioactive agent(s).
Control profile
Michel M Gensini from Flemington, NJ, age ~61 Get Report